Search alternatives:
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
-
121
Magnetic flux density in the x and z directions against the distance from the magnet.
Published 2025Subjects: -
122
-
123
-
124
Schematic of the experimental setup for the generation of ferrofluid droplets using a magnet.
Published 2025Subjects: -
125
-
126
-
127
-
128
-
129
Values of geometry function for some typical hydrophilic surface geometries.
Published 2025Subjects: -
130
Non-dimensional diameter of droplets versus magnetic and gravitational Bond Number.
Published 2025Subjects: -
131
Comparison of measured contact angle of ferrofluid droplets on hydrophilic and hydrophobic surfaces.
Published 2025Subjects: -
132
-
133
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
134
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
135
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
136
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
137
Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
138
Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
139
Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
140
Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”